首页 > 最新文献

International journal of physiology, pathophysiology and pharmacology最新文献

英文 中文
Extracellular vesicles and their therapeutic applications: a review article (part 2). 细胞外囊泡及其治疗应用:综述文章(第 2 部分)。
Pub Date : 2024-08-25 eCollection Date: 2024-01-01 DOI: 10.62347/AUPQ6330
Diana Rafieezadeh

Extracellular vesicles (EVs) have emerged as a fascinating area of research in molecular biology, with diverse therapeutic applications. These small membrane-bound structures, released by cells into the extracellular space, play a crucial role in intercellular communication and hold great potential for advancing medical treatments. The aim of this study is to have a narrative review on the use and therapeutic applications of EVs. Their unique characteristics, including stability, biocompatibility, and the ability to traverse biological barriers, make them promising tools for targeted drug delivery. By engineering EVs to encapsulate specific cargo molecules, such as therapeutic proteins, small interfering RNA (siRNA), or anti-cancer drugs, researchers can enhance drug stability and improve targeted delivery to desired cells or tissues. This approach can minimize off-target effects and improve therapeutic efficacy. Based on our literature search, we found that EVs can be used as biomarkers to predict diseases. Although much progress has been made in understanding the biology and function of exosomes, there are still unanswered questions that require further research. This includes identifying appropriate and safe techniques for producing exosomes in large quantities, determining which types of cells are suitable for exosome donor cells for therapeutic purposes, and investigating the safety of exosomes in human studies. Overall, the use of exosomes in clinical therapeutic applications requires a strong understanding of molecular signaling cascades and exosome profiles, as well as the specificity and sensitivity of biomarker and drug delivery methods.

细胞外囊泡(EVs)已成为分子生物学中一个引人入胜的研究领域,具有多种治疗用途。这些由细胞释放到细胞外空间的小型膜结合结构在细胞间的交流中发挥着至关重要的作用,在促进医学治疗方面具有巨大的潜力。本研究旨在对 EVs 的使用和治疗应用进行叙述性综述。EVs具有独特的特性,包括稳定性、生物相容性和穿越生物屏障的能力,使其成为有前途的靶向药物递送工具。通过对 EVs 进行工程设计,使其包裹治疗蛋白质、小干扰 RNA (siRNA) 或抗癌药物等特定载体分子,研究人员可以提高药物的稳定性,并改善向所需细胞或组织的靶向递送。这种方法可以最大限度地减少脱靶效应,提高疗效。根据文献检索,我们发现 EVs 可用作预测疾病的生物标记物。尽管在了解外泌体的生物学特性和功能方面取得了很大进展,但仍有一些未解之谜需要进一步研究。这包括确定大量生产外泌体的适当而安全的技术,确定哪些类型的细胞适合作为外泌体供体细胞用于治疗目的,以及在人体研究中调查外泌体的安全性。总之,将外泌体用于临床治疗需要深入了解分子信号级联和外泌体特征,以及生物标记物和给药方法的特异性和敏感性。
{"title":"Extracellular vesicles and their therapeutic applications: a review article (part 2).","authors":"Diana Rafieezadeh","doi":"10.62347/AUPQ6330","DOIUrl":"10.62347/AUPQ6330","url":null,"abstract":"<p><p>Extracellular vesicles (EVs) have emerged as a fascinating area of research in molecular biology, with diverse therapeutic applications. These small membrane-bound structures, released by cells into the extracellular space, play a crucial role in intercellular communication and hold great potential for advancing medical treatments. The aim of this study is to have a narrative review on the use and therapeutic applications of EVs. Their unique characteristics, including stability, biocompatibility, and the ability to traverse biological barriers, make them promising tools for targeted drug delivery. By engineering EVs to encapsulate specific cargo molecules, such as therapeutic proteins, small interfering RNA (siRNA), or anti-cancer drugs, researchers can enhance drug stability and improve targeted delivery to desired cells or tissues. This approach can minimize off-target effects and improve therapeutic efficacy. Based on our literature search, we found that EVs can be used as biomarkers to predict diseases. Although much progress has been made in understanding the biology and function of exosomes, there are still unanswered questions that require further research. This includes identifying appropriate and safe techniques for producing exosomes in large quantities, determining which types of cells are suitable for exosome donor cells for therapeutic purposes, and investigating the safety of exosomes in human studies. Overall, the use of exosomes in clinical therapeutic applications requires a strong understanding of molecular signaling cascades and exosome profiles, as well as the specificity and sensitivity of biomarker and drug delivery methods.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 4","pages":"81-88"},"PeriodicalIF":0.0,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of PET/CT and PET/MRI in central nervous system tumors, a narrative review. 中枢神经系统肿瘤 PET/CT 和 PET/MRI 的比较,综述。
Pub Date : 2024-08-25 eCollection Date: 2024-01-01 DOI: 10.62347/UMDS1961
Farshad Riahi, Pooya Kiani, Aryan Golabbakhsh, Matin Khanezarrin, Mohammadjavad Abbaspour, Seyed Amirhossein Dormiani Tabatabaei, Shahin Fesharaki, Seyed Hamed Tooyserkani, Rozhin Bakhshi, Sara Azizollahi, Hossein Mohammadi

Background: PET/CT and PET/MRI are two useful imaging modalities in neuro-oncology. Our aim was to review the existing literature on the benefits and drawbacks of using PET/CT and PET/MRI in the diagnosis of central nervous system (CNS) tumors.

Methods: A literature search was conducted using valid databases, limited to English-language articles published between 2010 and 2023, and independently reviewed by two reviewers. A standard data extraction form was used to extract data from the included papers. The results were condensed and narratively presented, accompanied by supporting data from the included investigations.

Results: The study analyzed 28 articles, mostly from Europe. The results varied, with some studies comparing PET/CT and PET/MRI, examining specific types of brain tumors, pediatric tumors, or focusing on specific PET/CT or PET/MRI modalities. The synthesis aimed to provide a comprehensive overview of PET/CT and PET/MRI use in CNS malignancies.

Conclusions: PET/MRI offers promising advantages in neuro-oncology diagnosis and follow-up imaging, but its use should be prioritized in appropriate situations.

背景:PET/CT 和 PET/MRI 是神经肿瘤学中两种有用的成像模式。我们的目的是回顾现有文献,了解使用 PET/CT 和 PET/MRI 诊断中枢神经系统(CNS)肿瘤的利弊:使用有效的数据库进行文献检索,仅限于 2010 年至 2023 年间发表的英文文章,并由两名审稿人进行独立审阅。采用标准数据提取表从纳入的论文中提取数据。研究结果被浓缩并以叙述的方式呈现,并附有所纳入调查的支持数据:研究分析了 28 篇文章,其中大部分来自欧洲。结果各不相同,有些研究比较了PET/CT和PET/MRI,研究了特定类型的脑肿瘤、儿童肿瘤,或侧重于特定的PET/CT或PET/MRI模式。本综述旨在全面概述 PET/CT 和 PET/MRI 在中枢神经系统恶性肿瘤中的应用:结论:PET/MRI 在神经肿瘤学诊断和随访成像方面具有广阔的前景,但应在适当的情况下优先使用。
{"title":"Comparison of PET/CT and PET/MRI in central nervous system tumors, a narrative review.","authors":"Farshad Riahi, Pooya Kiani, Aryan Golabbakhsh, Matin Khanezarrin, Mohammadjavad Abbaspour, Seyed Amirhossein Dormiani Tabatabaei, Shahin Fesharaki, Seyed Hamed Tooyserkani, Rozhin Bakhshi, Sara Azizollahi, Hossein Mohammadi","doi":"10.62347/UMDS1961","DOIUrl":"10.62347/UMDS1961","url":null,"abstract":"<p><strong>Background: </strong>PET/CT and PET/MRI are two useful imaging modalities in neuro-oncology. Our aim was to review the existing literature on the benefits and drawbacks of using PET/CT and PET/MRI in the diagnosis of central nervous system (CNS) tumors.</p><p><strong>Methods: </strong>A literature search was conducted using valid databases, limited to English-language articles published between 2010 and 2023, and independently reviewed by two reviewers. A standard data extraction form was used to extract data from the included papers. The results were condensed and narratively presented, accompanied by supporting data from the included investigations.</p><p><strong>Results: </strong>The study analyzed 28 articles, mostly from Europe. The results varied, with some studies comparing PET/CT and PET/MRI, examining specific types of brain tumors, pediatric tumors, or focusing on specific PET/CT or PET/MRI modalities. The synthesis aimed to provide a comprehensive overview of PET/CT and PET/MRI use in CNS malignancies.</p><p><strong>Conclusions: </strong>PET/MRI offers promising advantages in neuro-oncology diagnosis and follow-up imaging, but its use should be prioritized in appropriate situations.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 4","pages":"89-95"},"PeriodicalIF":0.0,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of connexin36 with adherens junctions at mixed synapses and distinguishing electrophysiological features of those at mossy fiber terminals in rat ventral hippocampus. 大鼠腹侧海马混合突触中连接蛋白36与粘连接头的关联以及苔藓纤维末端的电生理特征的区分。
Pub Date : 2024-06-15 eCollection Date: 2024-01-01 DOI: 10.62347/RTMH4490
Deepthi Thomas, Antonia Recabal-Beyer, Joanne Mm Senecal, Demitre Serletis, Bruce D Lynn, Michael F Jackson, James I Nagy

Background: Granule cells in the hippocampus project axons to hippocampal CA3 pyramidal cells where they form large mossy fiber terminals. We have reported that these terminals contain the gap junction protein connexin36 (Cx36) specifically in the stratum lucidum of rat ventral hippocampus, thus creating morphologically mixed synapses that have the potential for dual chemical/electrical transmission.

Methodology: Here, we used various approaches to characterize molecular and electrophysiological relationships between the Cx36-containing gap junctions at mossy fiber terminals and their postsynaptic elements and to examine molecular relationships at mixed synapses in the brainstem.

Results: In rat and human ventral hippocampus, many of these terminals, identified by their selective expression of vesicular zinc transporter-3 (ZnT3), displayed multiple, immunofluorescent Cx36-puncta representing gap junctions, which were absent at mossy fiber terminals in the dorsal hippocampus. In rat, these were found in close proximity to the protein constituents of adherens junctions (i.e., N-cadherin and nectin-1) that are structural hallmarks of mossy fiber terminals, linking these terminals to the dendritic shafts of CA3 pyramidal cells, thus indicating the loci of gap junctions at these contacts. Cx36-puncta were also associated with adherens junctions at mixed synapses in the brainstem, supporting emerging views of the structural organization of the adherens junction-neuronal gap junction complex. Electrophysiologically induced long-term potentiation (LTP) of field responses evoked by mossy fiber stimulation was greater in the ventral than dorsal hippocampus.

Conclusions: The electrical component of transmission at mossy fiber terminals may contribute to enhanced LTP responses in the ventral hippocampus.

背景:海马颗粒细胞的轴突投射到海马CA3锥体细胞,在那里形成大的苔藓纤维终端。方法:在此,我们采用各种方法描述苔藓纤维末端含 Cx36 的缝隙连接及其突触后元件之间的分子和电生理关系,并研究脑干混合突触的分子关系:结果:在大鼠和人的腹侧海马中,许多通过选择性表达囊泡锌转运体-3(ZnT3)而被识别的末端显示了多个免疫荧光Cx36-puncta代表的间隙连接,这些间隙连接在海马背侧的苔藓纤维末端是不存在的。在大鼠体内,这些结点与苔藓纤维末端的结构标志--粘连接头的蛋白质成分(即 N-cadherin和 nectin-1)非常接近,它们将苔藓纤维末端与 CA3 锥体细胞的树突轴连接起来,从而表明了这些接触点上的间隙连接位置。在脑干的混合突触中,Cx36-结点也与粘连接头相关,这支持了新出现的粘连接头-神经元间隙连接复合体结构组织的观点。苔藓纤维刺激诱发的场反应的电生理诱导长期电位(LTP)在海马腹侧比背侧更强:结论:苔藓纤维末端传输的电成分可能有助于增强腹侧海马的 LTP 反应。
{"title":"Association of connexin36 with adherens junctions at mixed synapses and distinguishing electrophysiological features of those at mossy fiber terminals in rat ventral hippocampus.","authors":"Deepthi Thomas, Antonia Recabal-Beyer, Joanne Mm Senecal, Demitre Serletis, Bruce D Lynn, Michael F Jackson, James I Nagy","doi":"10.62347/RTMH4490","DOIUrl":"10.62347/RTMH4490","url":null,"abstract":"<p><strong>Background: </strong>Granule cells in the hippocampus project axons to hippocampal CA3 pyramidal cells where they form large mossy fiber terminals. We have reported that these terminals contain the gap junction protein connexin36 (Cx36) specifically in the stratum lucidum of rat ventral hippocampus, thus creating morphologically mixed synapses that have the potential for dual chemical/electrical transmission.</p><p><strong>Methodology: </strong>Here, we used various approaches to characterize molecular and electrophysiological relationships between the Cx36-containing gap junctions at mossy fiber terminals and their postsynaptic elements and to examine molecular relationships at mixed synapses in the brainstem.</p><p><strong>Results: </strong>In rat and human ventral hippocampus, many of these terminals, identified by their selective expression of vesicular zinc transporter-3 (ZnT3), displayed multiple, immunofluorescent Cx36-puncta representing gap junctions, which were absent at mossy fiber terminals in the dorsal hippocampus. In rat, these were found in close proximity to the protein constituents of adherens junctions (i.e., N-cadherin and nectin-1) that are structural hallmarks of mossy fiber terminals, linking these terminals to the dendritic shafts of CA3 pyramidal cells, thus indicating the loci of gap junctions at these contacts. Cx36-puncta were also associated with adherens junctions at mixed synapses in the brainstem, supporting emerging views of the structural organization of the adherens junction-neuronal gap junction complex. Electrophysiologically induced long-term potentiation (LTP) of field responses evoked by mossy fiber stimulation was greater in the ventral than dorsal hippocampus.</p><p><strong>Conclusions: </strong>The electrical component of transmission at mossy fiber terminals may contribute to enhanced LTP responses in the ventral hippocampus.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 3","pages":"28-54"},"PeriodicalIF":0.0,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patterns of connexin36 and eGFP reporter expression among motoneurons in spinal sexually dimorphic motor nuclei in mouse. 小鼠脊髓性双态运动核中运动神经元的连接蛋白36和eGFP报告表达模式
Pub Date : 2024-06-15 eCollection Date: 2024-01-01 DOI: 10.62347/OGWV9376
Prabhisha Silwal, Pratyaksh Singhal, Joanne Mm Senecal, Julie Em Senecal, Bruce D Lynn, James I Nagy

Background: Sexually dimorphic spinal motoneurons (MNs) in the dorsomedial nucleus (DMN) and dorsolateral nucleus (DLN) as well as those in the cremaster nucleus are involved in reproductive behaviours, and the cremaster nucleus additionally contributes to testicular thermoregulation. It has been reported that MNs in DMN and DLN are extensively linked by gap junctions forming electrical synapses composed of connexin36 (Cx36) and there is evidence that subpopulation of MNs in the cremaster nucleus are also electrically coupled by these synapses.

Methodology: We used immunofluorescence methods to detect enhanced green fluorescent protein (eGFP) reporter for Cx36 expression in these motor nuclei.

Results: We document in male mice that about half the MNs in each of DMN and DLN express eGFP, while the remaining half do not. Further, we found that the eGFP+ vs. eGFP- subsets of MNs in each of these motor nuclei innervate different target muscles; eGFP+ MNs in DMN and DLN project to sexually dimorphic bulbocavernosus and ischiocavernosus muscles, while the eGFP- subsets project to sexually non-dimorphic anal and external urethral sphincter muscles. Similarly, eGFP+ vs. eGFP- cremaster MNs were found to project to anatomically distinct portions of the cremaster muscle. By immunofluorescence, nearly all motoneurons in both DMN and DLN displayed punctate labelling for Cx36, including at eGFP+/eGFP+, eGFP+/eGFP- and eGFP-/eGFP- cell appositions.

Conclusions: Most if not all motoneurons in DMN and DLN are electrically coupled, including sexually dimorphic and non-dimorphic motoneurons with each other, despite absence of eGFP reporter in the non-dimorphic populations in these nuclei that have selective projections to sexually non-dimorphic target muscles.

背景:背内侧核(DMN)和背外侧核(DLN)以及襞核中的性双态脊髓运动神经元(MNs)参与生殖行为,襞核还对睾丸的体温调节做出了贡献。有报道称,DMN和DLN中的MN通过间隙连接广泛相连,形成由Connexin36(Cx36)组成的电突触,有证据表明,嵴核中的亚群MN也通过这些突触进行电耦合:我们使用免疫荧光方法检测这些运动核中 Cx36 表达的增强型绿色荧光蛋白(eGFP)报告物:结果:我们在雄性小鼠体内发现,DMN和DLN中约有一半的运动核表达eGFP,而其余一半则不表达。此外,我们还发现,这些运动核中eGFP+与eGFP-亚群分别支配不同的靶肌肉;DMN和DLN中eGFP+的MN投射到性双态的球海绵体肌和异海绵体肌,而eGFP-亚群则投射到性非双态的肛门肌和外尿道括约肌。同样,发现 eGFP+ 与 eGFP- 的嵴状肌 MN 投射到解剖学上不同的嵴状肌部分。通过免疫荧光,DMN和DLN中几乎所有的运动神经元都显示出Cx36的点状标记,包括在eGFP+/eGFP+、eGFP+/eGFP-和eGFP-/eGFP-细胞连接处:结论:DMN和DLN中的大多数(如果不是全部的话)运动神经元是电耦合的,包括性双态和非双态运动神经元之间的电耦合。
{"title":"Patterns of connexin36 and eGFP reporter expression among motoneurons in spinal sexually dimorphic motor nuclei in mouse.","authors":"Prabhisha Silwal, Pratyaksh Singhal, Joanne Mm Senecal, Julie Em Senecal, Bruce D Lynn, James I Nagy","doi":"10.62347/OGWV9376","DOIUrl":"10.62347/OGWV9376","url":null,"abstract":"<p><strong>Background: </strong>Sexually dimorphic spinal motoneurons (MNs) in the dorsomedial nucleus (DMN) and dorsolateral nucleus (DLN) as well as those in the cremaster nucleus are involved in reproductive behaviours, and the cremaster nucleus additionally contributes to testicular thermoregulation. It has been reported that MNs in DMN and DLN are extensively linked by gap junctions forming electrical synapses composed of connexin36 (Cx36) and there is evidence that subpopulation of MNs in the cremaster nucleus are also electrically coupled by these synapses.</p><p><strong>Methodology: </strong>We used immunofluorescence methods to detect enhanced green fluorescent protein (eGFP) reporter for Cx36 expression in these motor nuclei.</p><p><strong>Results: </strong>We document in male mice that about half the MNs in each of DMN and DLN express eGFP, while the remaining half do not. Further, we found that the eGFP<sup>+</sup> vs. eGFP<sup>-</sup> subsets of MNs in each of these motor nuclei innervate different target muscles; eGFP<sup>+</sup> MNs in DMN and DLN project to sexually dimorphic bulbocavernosus and ischiocavernosus muscles, while the eGFP<sup>-</sup> subsets project to sexually non-dimorphic anal and external urethral sphincter muscles. Similarly, eGFP<sup>+</sup> vs. eGFP<sup>-</sup> cremaster MNs were found to project to anatomically distinct portions of the cremaster muscle. By immunofluorescence, nearly all motoneurons in both DMN and DLN displayed punctate labelling for Cx36, including at eGFP<sup>+</sup>/eGFP<sup>+</sup>, eGFP<sup>+</sup>/eGFP<sup>-</sup> and eGFP<sup>-</sup>/eGFP<sup>-</sup> cell appositions.</p><p><strong>Conclusions: </strong>Most if not all motoneurons in DMN and DLN are electrically coupled, including sexually dimorphic and non-dimorphic motoneurons with each other, despite absence of eGFP reporter in the non-dimorphic populations in these nuclei that have selective projections to sexually non-dimorphic target muscles.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 3","pages":"55-76"},"PeriodicalIF":0.0,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits and quick adoption of the use of Sugammadex in a busy practice setting. 在繁忙的诊疗环境中使用舒格迈司的益处和快速应用。
Pub Date : 2024-06-15 eCollection Date: 2024-01-01 DOI: 10.62347/WOOD9895
Vincent Devito, Fiore Toscano, Rany Makaryus

The everyday clinical practice of anesthesia has been transformed by the new reversal agent Sugammadex. With multiple benefits to this agent, including immediate reversibility of certain neuromuscular blocking agents, a more robust reversal, and the ability to keep a deeper plane of paralysis throughout surgical procedures, this medication has provided anesthesiologists with a new and improved ability to provide high quality care to their patients. The effectiveness of the reversal provided by this agent has also improved the incidence of post-operative complications relating to improper reversal and the need for reintubations. With the new American Society of Anesthesiologists (ASA) guidelines on neuromuscular blockade and its reversal, Sugammadex has been easily and quickly adopted into everyday clinical practice.

新型逆转剂 Sugammadex 改变了日常的麻醉临床实践。这种药物具有多种优点,包括可立即逆转某些神经肌肉阻滞剂、逆转能力更强以及能够在整个手术过程中保持较深的麻痹平面。这种药物所提供的有效逆转也改善了因逆转不当而导致的术后并发症的发生率以及重新插管的需求。随着美国麻醉医师协会(ASA)关于神经肌肉阻滞及其逆转的新指南的出台,舒格迈得已被方便快捷地应用到日常临床实践中。
{"title":"Benefits and quick adoption of the use of Sugammadex in a busy practice setting.","authors":"Vincent Devito, Fiore Toscano, Rany Makaryus","doi":"10.62347/WOOD9895","DOIUrl":"10.62347/WOOD9895","url":null,"abstract":"<p><p>The everyday clinical practice of anesthesia has been transformed by the new reversal agent Sugammadex. With multiple benefits to this agent, including immediate reversibility of certain neuromuscular blocking agents, a more robust reversal, and the ability to keep a deeper plane of paralysis throughout surgical procedures, this medication has provided anesthesiologists with a new and improved ability to provide high quality care to their patients. The effectiveness of the reversal provided by this agent has also improved the incidence of post-operative complications relating to improper reversal and the need for reintubations. With the new American Society of Anesthesiologists (ASA) guidelines on neuromuscular blockade and its reversal, Sugammadex has been easily and quickly adopted into everyday clinical practice.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 3","pages":"77-80"},"PeriodicalIF":0.0,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strong ion gap and anion gap corrected for albumin and lactate in patients with sepsis in the intensive care unit. 重症监护室脓毒症患者的强离子间隙和阴离子间隙(根据白蛋白和乳酸盐校正)。
Pub Date : 2024-04-15 eCollection Date: 2024-01-01 DOI: 10.62347/PTUU2265
Emmanouil Alevrakis, Dimitrios-Dorotheos Papadakis, Dimitrios Vagionas, Antonia Koutsoukou, Konstantinos Pontikis, Nikoletta Rovina, Ioannis Vasileiadis

Introduction: Metabolic acidosis is very common amongst critically ill sepsis patients partly due to the presence of unmeasured ions in serum. These ions can be detected by anion gap (AG) or strong ion gap (SIG) concentration values. The purpose of this study is to assess the correlation and potential agreement of the two methods in critically ill patients with sepsis.

Materials and methods: The present is a retrospective study including septic patients admitted to the Intensive Care Unit from December 2014 to July 2016. The [SIG] and the [AG] corrected for albumin and lactate ([AGcl]) were calculated on admission and on sepsis remission or deterioration. The correlation of the two parameters was assessed in all patient groups using the Pearson correlation coefficient and linear regression analysis and the agreement with Bland-Altman plots. ROC survival curves were also generated for the patients in relation to the values of [AGcl], [SIG] and inorganic [SIG] ([SIGi]) on admission.

Results: There was a strong correlation linking [AGcl] and [SIG] values (r>0.9, P<0.05) in all patient groups. The results from all three linear regression equations were statistically significant as the models predicted the [AGcl] value from the [SIG] value with high accuracy. The mean difference of the two methods (i.e. [AGcl] - [SIG] in every patient separately) in septic patients on admission was 11.75 mEq/l with 95% limits of agreement [9.7-13.8]; in patients with sepsis deterioration, it was 11.8 mEq/l with 95% limits of agreement [9.8-13.7] and in patients with sepsis remission, it was 11.5 mEq/l with 95% limits of agreement [10.4-12.7]. ROC survival curves demonstrated a small area under the curve (AUC): [SIG] AUC: 0.479, 95% CI [0.351, 0.606], [SIGi] AUC: 0.581, 95% CI [0.457, 0.705], [AGcl] AUC: 0.529, 95% CI [0.401, 0.656].

Conclusion: [AGcl] and [SIG] demonstrate excellent correlation in septic patients, with a mean difference of about 12 mEq/l. Both parameters failed to demonstrate any predictive ability regarding patient mortality.

简介代谢性酸中毒在脓毒症重症患者中非常常见,部分原因是血清中存在无法测量的离子。这些离子可通过阴离子间隙(AG)或强离子间隙(SIG)浓度值检测到。本研究的目的是评估这两种方法在败血症重症患者中的相关性和潜在一致性:本研究是一项回顾性研究,包括 2014 年 12 月至 2016 年 7 月期间重症监护室收治的脓毒症患者。在入院时以及脓毒症缓解或恶化时计算[SIG]和经白蛋白和乳酸盐校正的[AG]([AGcl])。使用皮尔逊相关系数和线性回归分析评估了所有患者组中这两个参数的相关性,并使用布兰德-阿尔特曼图评估了两者的一致性。还根据患者入院时的[AGcl]、[SIG]和无机[SIG]([SIGi])值绘制了ROC生存曲线:结果:[AGcl]和[SIG]值之间存在很强的相关性(r>0.9,Pcl]值与[SIG]值之间的相关性准确度很高。脓毒症患者入院时两种方法的平均差异(即每位患者的[AGcl]-[SIG])为 11.75 mEq/l,95% 的吻合度为[9.7-13.8];脓毒症恶化患者的平均差异为 11.8 mEq/l,95% 的吻合度为[9.8-13.7];脓毒症缓解患者的平均差异为 11.5 mEq/l,95% 的吻合度为[10.4-12.7]。ROC 生存曲线显示曲线下面积(AUC)较小:[SIG] AUC:0.479,95% CI [0.351,0.606],[SIGi] AUC:0.581,95% CI [0.457,0.705],[AGcl] AUC:0.529,95% CI [0.401,0.656]:结论:[AGcl]和[SIG]在脓毒症患者中显示出极好的相关性,平均差异约为 12 mEq/l。这两个参数都无法预测患者的死亡率。
{"title":"Strong ion gap and anion gap corrected for albumin and lactate in patients with sepsis in the intensive care unit.","authors":"Emmanouil Alevrakis, Dimitrios-Dorotheos Papadakis, Dimitrios Vagionas, Antonia Koutsoukou, Konstantinos Pontikis, Nikoletta Rovina, Ioannis Vasileiadis","doi":"10.62347/PTUU2265","DOIUrl":"10.62347/PTUU2265","url":null,"abstract":"<p><strong>Introduction: </strong>Metabolic acidosis is very common amongst critically ill sepsis patients partly due to the presence of unmeasured ions in serum. These ions can be detected by anion gap (AG) or strong ion gap (SIG) concentration values. The purpose of this study is to assess the correlation and potential agreement of the two methods in critically ill patients with sepsis.</p><p><strong>Materials and methods: </strong>The present is a retrospective study including septic patients admitted to the Intensive Care Unit from December 2014 to July 2016. The [SIG] and the [AG] corrected for albumin and lactate ([AG<sub>cl</sub>]) were calculated on admission and on sepsis remission or deterioration. The correlation of the two parameters was assessed in all patient groups using the Pearson correlation coefficient and linear regression analysis and the agreement with Bland-Altman plots. ROC survival curves were also generated for the patients in relation to the values of [AG<sub>cl</sub>], [SIG] and inorganic [SIG] ([SIG<sub>i</sub>]) on admission.</p><p><strong>Results: </strong>There was a strong correlation linking [AG<sub>cl</sub>] and [SIG] values (r>0.9, P<0.05) in all patient groups. The results from all three linear regression equations were statistically significant as the models predicted the [AG<sub>cl</sub>] value from the [SIG] value with high accuracy. The mean difference of the two methods (i.e. [AG<sub>cl</sub>] - [SIG] in every patient separately) in septic patients on admission was 11.75 mEq/l with 95% limits of agreement [9.7-13.8]; in patients with sepsis deterioration, it was 11.8 mEq/l with 95% limits of agreement [9.8-13.7] and in patients with sepsis remission, it was 11.5 mEq/l with 95% limits of agreement [10.4-12.7]. ROC survival curves demonstrated a small area under the curve (AUC): [SIG] AUC: 0.479, 95% CI [0.351, 0.606], [SIG<sub>i</sub>] AUC: 0.581, 95% CI [0.457, 0.705], [AG<sub>cl</sub>] AUC: 0.529, 95% CI [0.401, 0.656].</p><p><strong>Conclusion: </strong>[AG<sub>cl</sub>] and [SIG] demonstrate excellent correlation in septic patients, with a mean difference of about 12 mEq/l. Both parameters failed to demonstrate any predictive ability regarding patient mortality.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 2","pages":"10-27"},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11101998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141066623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular vesicles and their therapeutic applications: a review article (part1). 细胞外囊泡及其治疗应用:综述文章(第一部分)。
Pub Date : 2024-02-25 eCollection Date: 2024-01-01
Diana Rafieezadeh, Aryan Rafieezadeh

Extracellular vesicles (EVs) have emerged as a captivating field of study in molecular biology with diverse applications in therapeutics. These small membrane-bound structures, released by cells into the extracellular space, play a vital role in intercellular communication and hold immense potential for advancing medical treatments. EVs, including exosomes, microvesicles, and apoptotic bodies, are classified based on size and biogenesis pathways, with exosomes being the most extensively studied. The aim of this study was to examine the molecular secretory pathway of exosomes and to discuss the medical applications of exosomes and the methods for employing them in laboratory models. The therapeutic potential of EVs has garnered significant attention. Their unique properties, such as stability, biocompatibility, and capacity to traverse biological barriers, make them promising vehicles for targeted drug delivery. By engineering EVs to carry specific cargo molecules, such as therapeutic proteins, small interfering Ribonucleic Acid (RNAs) (siRNAs), or anti-cancer drugs, researchers can enhance drug stability and improve their targeted delivery to specific cells or tissues. This approach has the potential to minimize off-target effects and increase therapeutic efficacy, offering a more precise and effective treatment strategy. EVs represent a captivating and rapidly evolving field with significant therapeutic implications. Their role in intercellular communication, targeted drug delivery, and regenerative medicine makes them valuable tools for advancing medical treatments. As our understanding of EV biology and their therapeutic applications continues to expand, we can expect remarkable advancements that will revolutionize the field of medicine and lead to more personalized and effective therapies.

细胞外囊泡(EVs)已成为分子生物学研究中一个令人着迷的领域,在治疗学中有着多种多样的应用。这些由细胞释放到细胞外空间的小型膜结合结构在细胞间通信中发挥着重要作用,在促进医学治疗方面具有巨大潜力。EVs包括外泌体、微囊泡和凋亡体,根据大小和生物生成途径进行分类,其中外泌体的研究最为广泛。本研究旨在研究外泌体的分子分泌途径,并探讨外泌体的医学应用及其在实验室模型中的应用方法。外泌体的治疗潜力已引起广泛关注。外泌体的独特性质,如稳定性、生物相容性和穿越生物屏障的能力,使其成为有前景的靶向药物递送载体。研究人员可通过对电动体进行工程设计,使其携带特定的载货分子,如治疗蛋白质、小干扰核糖核酸(RNA)(siRNA)或抗癌药物,从而提高药物的稳定性,并改善向特定细胞或组织的靶向递送。这种方法有可能最大限度地减少脱靶效应,提高疗效,提供更精确、更有效的治疗策略。EVs 是一个令人着迷且发展迅速的领域,具有重要的治疗意义。它们在细胞间通信、靶向给药和再生医学中的作用使其成为推动医学治疗的宝贵工具。随着我们对 EV 生物学及其治疗应用的了解不断深入,我们可以预见,EV 的显著进步将彻底改变医学领域,并带来更个性化、更有效的疗法。
{"title":"Extracellular vesicles and their therapeutic applications: a review article (part1).","authors":"Diana Rafieezadeh, Aryan Rafieezadeh","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Extracellular vesicles (EVs) have emerged as a captivating field of study in molecular biology with diverse applications in therapeutics. These small membrane-bound structures, released by cells into the extracellular space, play a vital role in intercellular communication and hold immense potential for advancing medical treatments. EVs, including exosomes, microvesicles, and apoptotic bodies, are classified based on size and biogenesis pathways, with exosomes being the most extensively studied. The aim of this study was to examine the molecular secretory pathway of exosomes and to discuss the medical applications of exosomes and the methods for employing them in laboratory models. The therapeutic potential of EVs has garnered significant attention. Their unique properties, such as stability, biocompatibility, and capacity to traverse biological barriers, make them promising vehicles for targeted drug delivery. By engineering EVs to carry specific cargo molecules, such as therapeutic proteins, small interfering Ribonucleic Acid (RNAs) (siRNAs), or anti-cancer drugs, researchers can enhance drug stability and improve their targeted delivery to specific cells or tissues. This approach has the potential to minimize off-target effects and increase therapeutic efficacy, offering a more precise and effective treatment strategy. EVs represent a captivating and rapidly evolving field with significant therapeutic implications. Their role in intercellular communication, targeted drug delivery, and regenerative medicine makes them valuable tools for advancing medical treatments. As our understanding of EV biology and their therapeutic applications continues to expand, we can expect remarkable advancements that will revolutionize the field of medicine and lead to more personalized and effective therapies.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"16 1","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2024-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11007590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between patellofemoral osteoarthritis with demographic features and anatomical variants of the knee in non-traumatic patients. 非创伤性患者髌骨骨关节炎与膝关节人口学特征和解剖学变异之间的关系。
Pub Date : 2023-12-15 eCollection Date: 2023-01-01
Ghazaleh Jamalipour Soufi, Ali Hekmatnia, Farzaneh Hekmatnia, Andrew Parviz Zarei, Mahshid Bahrami, Sina Rasti, Farshad Riahi

Background: Patellofemoral osteoarthritis (PFOA) is a common cause of knee discomfort and impairment, particularly among athletes. The development of PFOA has been associated with anatomical knee variations, such as trochlear dysplasia and patella alta. However, the relationship between these anatomical variants and the development of PFOA remains poorly understood. This study aimed to investigate the association between PFOA and knee anatomical variants in a cohort of patients.

Methods: The study included 200 patients with PFOA and 200 healthy controls. In this study, we investigate the relationship of osteoarthritis with both anatomical variants and demographic characteristics. The participants underwent Magnetic resonance imaging (MRI) evaluation of the knee, and anatomical variants including trochlear dysplasia and patella alta were assessed. The severity of PFOA was also graded based on cartilage area and depth, as well as the bone marrow involvement and presence of osteophytes.

Results: Statistically significant differences were observed between the two groups in terms of Tibial tuberosity-trochlear groove (TT-TG) distance, patella position, trochlear dysplasia, and Insall-Salvati ratio. The mean TT-TG distance, prevalence of alta patella position, and Insall-Salvati ratio were significantly higher in cases (P<0.001 for all), and cases had a higher incidence of trochlear dysplasia (P<0.001). There were no significant differences between cases and controls regarding patella baja.

Conclusion: Anatomical knee variants, including the TT-TG distance, trochlear dysplasia, and Insall-Salvati ratio, are significant risk factors for PFOA progression. The results also indicate that higher BMI and older age are significantly associated with more measures of MRI Osteoarthritis Knee Score (MOAKS) than demographic information. Among anatomical variants, a higher TT-TG distance and an increased grade of trochlear dysplasia show a significant relationship with more measures of MOAKS. Understanding the relationship between these factors has important clinical and research implications and can help inform the development of new treatments.

背景:髌骨骨关节炎(PFOA)是造成膝关节不适和损伤的常见原因,尤其是在运动员中。髌骨股骨关节炎的发生与膝关节解剖变异有关,如髌骨发育不良和髌骨上端。然而,人们对这些解剖变异与 PFOA 发病之间的关系仍然知之甚少。本研究旨在调查一组患者的 PFOA 与膝关节解剖变异之间的关系:研究包括 200 名 PFOA 患者和 200 名健康对照者。在这项研究中,我们调查了骨关节炎与解剖变异和人口特征的关系。参与者接受了膝关节磁共振成像(MRI)评估,并对解剖变异进行了评估,包括髌骨发育不良和髌骨突出。此外,还根据软骨面积和深度以及骨髓受累情况和骨质增生的存在情况对 PFOA 的严重程度进行了分级:结果:两组患者在胫骨结节-椎弓根沟(TT-TG)距离、髌骨位置、椎弓根发育不良和Insall-Salvati比值方面存在明显统计学差异。病例的平均胫骨结节-胫骨沟距离、髌骨位置和Insall-Salvati比率均明显高于对照组(结论:胫骨结节-胫骨沟距离、髌骨位置和Insall-Salvati比率均高于对照组):包括TT-TG距离、髌骨发育不良和Insall-Salvati比率在内的膝关节解剖变异是PFOA进展的重要风险因素。研究结果还表明,与人口统计学信息相比,较高的体重指数(BMI)和较大的年龄与更多的核磁共振成像骨关节炎膝关节评分(MOAKS)相关。在解剖变异中,较高的 TT-TG 距离和较高的套管发育不良等级与较多的 MOAKS 测量值有显著关系。了解这些因素之间的关系具有重要的临床和研究意义,有助于开发新的治疗方法。
{"title":"Association between patellofemoral osteoarthritis with demographic features and anatomical variants of the knee in non-traumatic patients.","authors":"Ghazaleh Jamalipour Soufi, Ali Hekmatnia, Farzaneh Hekmatnia, Andrew Parviz Zarei, Mahshid Bahrami, Sina Rasti, Farshad Riahi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Patellofemoral osteoarthritis (PFOA) is a common cause of knee discomfort and impairment, particularly among athletes. The development of PFOA has been associated with anatomical knee variations, such as trochlear dysplasia and patella alta. However, the relationship between these anatomical variants and the development of PFOA remains poorly understood. This study aimed to investigate the association between PFOA and knee anatomical variants in a cohort of patients.</p><p><strong>Methods: </strong>The study included 200 patients with PFOA and 200 healthy controls. In this study, we investigate the relationship of osteoarthritis with both anatomical variants and demographic characteristics. The participants underwent Magnetic resonance imaging (MRI) evaluation of the knee, and anatomical variants including trochlear dysplasia and patella alta were assessed. The severity of PFOA was also graded based on cartilage area and depth, as well as the bone marrow involvement and presence of osteophytes.</p><p><strong>Results: </strong>Statistically significant differences were observed between the two groups in terms of Tibial tuberosity-trochlear groove (TT-TG) distance, patella position, trochlear dysplasia, and Insall-Salvati ratio. The mean TT-TG distance, prevalence of alta patella position, and Insall-Salvati ratio were significantly higher in cases (P<0.001 for all), and cases had a higher incidence of trochlear dysplasia (P<0.001). There were no significant differences between cases and controls regarding patella baja.</p><p><strong>Conclusion: </strong>Anatomical knee variants, including the TT-TG distance, trochlear dysplasia, and Insall-Salvati ratio, are significant risk factors for PFOA progression. The results also indicate that higher BMI and older age are significantly associated with more measures of MRI Osteoarthritis Knee Score (MOAKS) than demographic information. Among anatomical variants, a higher TT-TG distance and an increased grade of trochlear dysplasia show a significant relationship with more measures of MOAKS. Understanding the relationship between these factors has important clinical and research implications and can help inform the development of new treatments.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 6","pages":"142-149"},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139428102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between pleurodesis results by 50% glucose solution, versus Bleomycin pleurodesis in patients with malignant pleural effusion. 恶性胸腔积液患者50%葡萄糖溶液胸膜清除率与博来霉素胸膜清除率的比较。
Pub Date : 2023-10-15 eCollection Date: 2023-01-01
Hamid Talebzadeh, Milad Nazari Sabet

Background: Following parapneumonic effusions, malignant pleural effusions (MPEs) stand as the second most common cause of exudative pleural effusions. These effusions typically remain unresponsive to systemic chemotherapy, necessitating novel therapeutic approaches. This study aims to ascertain the effectiveness of intrapleural injection with a 50% glucose solution and to compare it with intrapleural injection of Bleomycin sulfate in treating malignant pleural effusion.

Methods: This prospective, double-blind, randomized clinical trial was conducted at Al-Zahra Hospital in Isfahan. The study protocol gained approval from the Iranian Registry of Clinical Trials (IRCT code: IRCT20201013049017N1) (https://en.irct.ir/trial/52739). The study population encompassed patients with malignant pleural effusion. Sampling occurred through a census approach from October 2019 to March 2020. The first group received a pleurodesis solution containing 12.5 cc of 2% lidocaine with Bleomycin, while the second group received a solution comprising 200 cc of 50% glucose solution (10 grams of glucose) and 12.5 ml of 2% lidocaine, within the same volume. These solutions were injected into the pleural space via the chest tube.

Results: The complete response rate to treatment three months post-injection was 71.9% in the Bleomycin sulfate group and 65.6% in the 50% dextrose group. However, the difference between the two groups did not achieve statistical significance (P = 0.689). The incidence of post-injection fever and pain intensity exhibited comparability in both groups.

Conclusion: The treatment involving a combination of 50% glucose solution with Bleomycin for pleurodesis in patients with malignant pleural effusion demonstrated outcomes akin to other treatment options.

背景:恶性胸腔积液是排在肺旁积液之后的第二大常见原因。这些积液通常对全身化疗没有反应,因此需要新的治疗方法。本研究旨在探讨50%葡萄糖溶液胸腔内注射治疗恶性胸腔积液的效果,并与硫酸博莱霉素胸腔内注射治疗恶性胸腔积液的效果进行比较。方法:这项前瞻性、双盲、随机临床试验在伊斯法罕的Al-Zahra医院进行。该研究方案获得了伊朗临床试验注册中心(IRCT代码:IRCT20201013049017N1) (https://en.irct.ir/trial/52739)的批准。研究人群包括恶性胸腔积液患者。从2019年10月到2020年3月,通过人口普查方法进行了抽样。第一组接受含有12.5毫升2%利多卡因和博莱霉素的胸膜溶解溶液,而第二组接受含有200毫升50%葡萄糖溶液(10克葡萄糖)和12.5毫升2%利多卡因的溶液,体积相同。这些溶液通过胸管注入胸腔。结果:注射后3个月博莱霉素组治疗完全缓解率为71.9%,50%葡萄糖组治疗完全缓解率为65.6%。但两组间差异无统计学意义(P = 0.689)。两组患者注射后发热发生率和疼痛强度具有可比性。结论:50%葡萄糖溶液联合博来霉素治疗恶性胸腔积液患者胸膜积液的效果与其他治疗方案相似。
{"title":"Comparison between pleurodesis results by 50% glucose solution, versus Bleomycin pleurodesis in patients with malignant pleural effusion.","authors":"Hamid Talebzadeh, Milad Nazari Sabet","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Following parapneumonic effusions, malignant pleural effusions (MPEs) stand as the second most common cause of exudative pleural effusions. These effusions typically remain unresponsive to systemic chemotherapy, necessitating novel therapeutic approaches. This study aims to ascertain the effectiveness of intrapleural injection with a 50% glucose solution and to compare it with intrapleural injection of Bleomycin sulfate in treating malignant pleural effusion.</p><p><strong>Methods: </strong>This prospective, double-blind, randomized clinical trial was conducted at Al-Zahra Hospital in Isfahan. The study protocol gained approval from the Iranian Registry of Clinical Trials (IRCT code: IRCT20201013049017N1) (https://en.irct.ir/trial/52739). The study population encompassed patients with malignant pleural effusion. Sampling occurred through a census approach from October 2019 to March 2020. The first group received a pleurodesis solution containing 12.5 cc of 2% lidocaine with Bleomycin, while the second group received a solution comprising 200 cc of 50% glucose solution (10 grams of glucose) and 12.5 ml of 2% lidocaine, within the same volume. These solutions were injected into the pleural space via the chest tube.</p><p><strong>Results: </strong>The complete response rate to treatment three months post-injection was 71.9% in the Bleomycin sulfate group and 65.6% in the 50% dextrose group. However, the difference between the two groups did not achieve statistical significance (P = 0.689). The incidence of post-injection fever and pain intensity exhibited comparability in both groups.</p><p><strong>Conclusion: </strong>The treatment involving a combination of 50% glucose solution with Bleomycin for pleurodesis in patients with malignant pleural effusion demonstrated outcomes akin to other treatment options.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 5","pages":"134-141"},"PeriodicalIF":0.0,"publicationDate":"2023-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of laser radiation on glial fibrillary acidic protein and allograft inflammatory factor-1 expression in severed and surgically repaired sciatic nerve. 激光照射对切断和手术修复坐骨神经中胶质纤维酸性蛋白和同种异体炎症因子-1表达的影响。
Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Zinovii Yashchyshyn, Marko Kozyk, Kateryna Strubchevska, Sergiy Ziablitsev

Objective: Determine the effect of different spectrum laser radiations on the expression of Glial Fibrillary Acidic Protein (GFAP) and allograft inflammatory factor-1 (Iba-1) in the sciatic nerve during regeneration.

Methods: The experiment was performed on 60 lab Wistar rats weighing 200-250 g. The left sciatic nerve was severed and subsequent end-to-end epineural suturing was performed 10, 20, 30, and 45 minutes after neurotomy. Western blot and immunohistochemistry analyses were performed by means of polyclonal anti-GFAP antibodies (Thermo Fisher Scientific, USA) and anti-Iba-1 antibodies (Invitrogen, USA) 90 days after nerve repair.

Results: The use of green and blue spectrum laser radiation significantly increased GFAP protein expression regardless of the time when surgical nerve repair was performed after injury. The expression of Iba-1 and tubulin after blue spectrum laser radiation with a wavelength of 470 nm was significantly higher than the control values by 5.1-11.0 times. An increase in the expression of Iba-1 and tubulin was noted when a green spectrum laser with a wavelength of 560 nm was utilized and nerve suturing was performed 10 and 20 minutes after nerve injury. The green spectrum laser with a wavelength of 520 nm had no significant effect on the expression of Iba-1 and tubulin. Morphologically, the highest proliferative reaction of glia was recorded when using a blue spectrum laser.

Conclusions: Laser radiation with blue (470 nm) and green (560 nm) spectra, promoted the activation of GFAP-positive Schwann cells and nerve regeneration. Activation of microglia is a necessary component of nerve regeneration and the content of Iba-1 represented the efficiency of regeneration.

目的:探讨不同光谱激光照射对坐骨神经再生过程中胶质纤维酸性蛋白(GFAP)和同种异体炎症因子-1(Iba-1)表达的影响。方法:实验在60只体重200-250g的实验室Wistar大鼠上进行。切断左侧坐骨神经,并在神经切断后10、20、30和45分钟进行端到端的表神经缝合。在神经修复90天后,通过多克隆抗GFAP抗体(Thermo Fisher Scientific,USA)和抗Iba-1抗体(Invitrogen,USA)进行蛋白质印迹和免疫组织化学分析。结果:无论损伤后进行手术神经修复的时间如何,使用绿色和蓝色光谱激光辐射都能显著增加GFAP蛋白的表达。波长为470nm的蓝光谱激光照射后,Iba-1和微管蛋白的表达显著高于对照值5.1-11.0倍。当使用波长为560nm的绿色光谱激光并且在神经损伤后10分钟和20分钟进行神经缝合时,注意到Iba-1和微管蛋白的表达增加。波长为520nm的绿色光谱激光对Iba-1和微管蛋白的表达没有显著影响。形态学上,当使用蓝光谱激光时,记录到胶质细胞的最高增殖反应。结论:蓝光(470nm)和绿光(560nm)激光照射能促进GFAP阳性许旺细胞的活化和神经再生。小胶质细胞的活化是神经再生的必要组成部分,Iba-1的含量代表了再生的效率。
{"title":"The effect of laser radiation on glial fibrillary acidic protein and allograft inflammatory factor-1 expression in severed and surgically repaired sciatic nerve.","authors":"Zinovii Yashchyshyn,&nbsp;Marko Kozyk,&nbsp;Kateryna Strubchevska,&nbsp;Sergiy Ziablitsev","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Determine the effect of different spectrum laser radiations on the expression of Glial Fibrillary Acidic Protein (GFAP) and allograft inflammatory factor-1 (Iba-1) in the sciatic nerve during regeneration.</p><p><strong>Methods: </strong>The experiment was performed on 60 lab Wistar rats weighing 200-250 g. The left sciatic nerve was severed and subsequent end-to-end epineural suturing was performed 10, 20, 30, and 45 minutes after neurotomy. Western blot and immunohistochemistry analyses were performed by means of polyclonal anti-GFAP antibodies (Thermo Fisher Scientific, USA) and anti-Iba-1 antibodies (Invitrogen, USA) 90 days after nerve repair.</p><p><strong>Results: </strong>The use of green and blue spectrum laser radiation significantly increased GFAP protein expression regardless of the time when surgical nerve repair was performed after injury. The expression of Iba-1 and tubulin after blue spectrum laser radiation with a wavelength of 470 nm was significantly higher than the control values by 5.1-11.0 times. An increase in the expression of Iba-1 and tubulin was noted when a green spectrum laser with a wavelength of 560 nm was utilized and nerve suturing was performed 10 and 20 minutes after nerve injury. The green spectrum laser with a wavelength of 520 nm had no significant effect on the expression of Iba-1 and tubulin. Morphologically, the highest proliferative reaction of glia was recorded when using a blue spectrum laser.</p><p><strong>Conclusions: </strong>Laser radiation with blue (470 nm) and green (560 nm) spectra, promoted the activation of GFAP-positive Schwann cells and nerve regeneration. Activation of microglia is a necessary component of nerve regeneration and the content of Iba-1 represented the efficiency of regeneration.</p>","PeriodicalId":94056,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 4","pages":"115-124"},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509562/pdf/ijppp0015-0115.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41166312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of physiology, pathophysiology and pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1